<DOC>
	<DOCNO>NCT01476930</DOCNO>
	<brief_summary>Migraine common recurrent headache . Current therapy migraine headache consist multiple drug group control attack prophylaxis recurrent attack . Emerging alternative medicine worldwide lead investigator evaluate efficacy cup therapy plus SERKANGABIN syrup treatment migraine headache . Severity , duration frequency attack migraine headache evaluate two group six month presentation .</brief_summary>
	<brief_title>Cupping Serkangabin Versus Conventional Migraine Treatment</brief_title>
	<detailed_description>In randomize controlled trial investigator randomly assign 76 patient migraine cup therapy plus SERKANGABIN receive conventional medical treatment . The use CAM migraine grow phenomenon . Migraine patient seek explore conventional CAM approach . Wet cup ancient medical technique still use several contemporary society . It use management hypertension , diabetes mellitus , headache , renal biliary stone maintain health . Little experimental study devote test efficacy treat migraine headache . Investigators plan study evaluation therapeutic efficacy wet cup Iranian traditional medicine preparation , SERKANGABIN treatment migraine headache compare current medicine protocol . SERKANGABIN preparation honey , vinegar distil mint water traditional Iranian medicine believe therapeutic effect many disease ( diabetes mellitus , hypertension , hyperlipidemia , osteoarthritis , chronic obstructive airway disease , interstitial lung disease , hepatitis , fatty liver , ischemic heart disease , migraine , cerebrovascular disease )</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>migraine headache without aura uncontrolled hypertension ischemic heart disease cardiac arrhythmia symptomatic WolffParkinsonWhite syndrome previous stroke transient ischemic attack severe liver renal impairment severe disable medical condition history alcohol analgesic psychotropic drug abuse contraindication know hypersensitivity study drug current use use previous 2 week MAOinhibitors pain disorder migraine primary presenting problem current psychological treatment , psychiatric disorder need immediate priority treatment current plan breast feeding pregnancy unwillingness use establish contraceptive method non compliance patient present time determine treatment evaluation</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>migraine</keyword>
	<keyword>prophylactic treatment</keyword>
	<keyword>cup</keyword>
	<keyword>serkangabin</keyword>
</DOC>